News

Pharmabiz13h
UK MHRA grants marketing authorisation to Biogen’s omaveloxolone to treat Friedreich’s ataxia
UK MHRA grants marketing authorisation to Biogen’s omaveloxolone to treat Friedreich’s ataxia: United Kingdom Friday, April 25, 2025, 12:00 Hrs [IST] The Medicines and Healthc ...
PMLive1d
Biogen’s Skyclarys granted MHRA approval for rare movement disorder Friedreich’s ataxia
Biogen’s Skyclarys (omaveloxolone) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the ...
The Pharma Letter1d
MHRA approves first UK treatment for Friedreich’s ataxia
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Skyclarys (omaveloxolone), the first treatment ...
Pharmaceutical Technology on MSN1d
Biogen’s Friedreich’s ataxia treatment authorised in UK
Friedreich's ataxia is a widespread hereditary ataxia type, affecting a minimum of one in every 50,000 individuals. It is c ...
Local woman with rare disease spearheading effort to educate more people about handicapped parking spots
A local woman with a rare disease is leading an effort to draw awareness to an issue that’s important to her and others who ...
Mirage News2d
MHRA Greenlights UKs First Friedreichs Ataxia Drug
As with all products, we will keep its safety under close review. The Medicines and Healthcare products Regulatory Agency ...